Clinical Trial Update: Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

View source ↗

Summary

Recruitment is ongoing for Perspectum's Haemdall study to develop a quantitative MRI biomarker for infratentorial superficial siderosis of the central nervous s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Siderosis of the Central Nervous System

Snippet

Sponsor: Perspectum | Conditions: Superficial Siderosis | Status: RECRUITING